These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 453354)

  • 1. A systematic investigation of tardive dyskinesia in inpatients.
    Smith JM; Kucharski LT; Oswald WT; Waterman LJ
    Am J Psychiatry; 1979 Jul; 136(7):918-22. PubMed ID: 453354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instrument measurement of lingual force variability reflects tardive tongue dyskinesia.
    Koning JP; Tenback DE; Kahn RS; Van Schelven LJ; Van Harten PN
    J Med Eng Technol; 2010 Jan; 34(1):71-7. PubMed ID: 19929569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does tardive dysmentia really exist?
    Lavania S; Praharaj SK; Bains HS; Kumar S; Rathore DM; Mohanty S; Nayak M
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):58-62. PubMed ID: 23487194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
    Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
    Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale.
    Rey JM; Hunt GE; Johnson GF
    Aust N Z J Psychiatry; 1981 Mar; 15(1):33-7. PubMed ID: 6973337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tardive dyskinesia. AIMS (Abnormal Involuntary Movement Scale) as a diagnostic and research tool].
    Burti L; Parolin A; Zanotelli R
    Minerva Med; 1981 Oct; 72(42):2829-36. PubMed ID: 7312199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of a tardive dyskinesia videotape rating technique.
    Barnes TR; Trauer T
    Br J Psychiatry; 1982 May; 140():508-15. PubMed ID: 7104534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not all that moves is tardive dyskinesia.
    Khot V; Wyatt RJ
    Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
    Muscettola G; Barbato G; de Bartolomeis A; Monteleone P; Pickar D
    Psychiatry Res; 1990 Sep; 33(3):259-67. PubMed ID: 2243901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.
    Raja M
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):145-51. PubMed ID: 7669821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia and hospital discharge.
    Kucharski LT; Smith JM; Dunn DD
    J Nerv Ment Dis; 1980 Apr; 168(4):215-8. PubMed ID: 6102592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in patients with tardive dyskinesia.
    Myslobodsky MS; Tomer R; Holden T; Kempler S; Sigal M
    J Nerv Ment Dis; 1985 Mar; 173(3):156-60. PubMed ID: 3973576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-syndromes of tardive dyskinesia and some clinical correlates.
    Brown KW; White T
    Psychol Med; 1992 Nov; 22(4):923-7. PubMed ID: 1488488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of patients with tardive dyskinesias].
    Held T; Weber T; Krausz H; Ahle G; Hager B; Alfter D; Schulze T; Knapp M; Maier W; Rietschel M
    Fortschr Neurol Psychiatr; 2000 Jul; 68(7):321-31. PubMed ID: 10945158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.